Greenpeace Slams Revised US Chemicals Act

© Greenpeace / Pierre Gleizes
© Greenpeace / Pierre Gleizes

Environmental advocacy organization Greenpeace has criticized the new Toxic Substances Control Act (TSCA) passed by the US House of Representatives as “the weakest of all US environmental statutes,” which it said “will leave the majority of the 85,000 chemicals in toys, clothes, homes, schools, and workplaces unregulated and untested for their health effects.”

Instead of drafting new legislation based on the generally more progressive state rules passed since the original TSCA act took hold, Congress listened to the “chemical lobby” and produced a toothless act that limits stronger state regulation and keeping weak federal safety standards, Greenpeace said.  

As TSCA hasn't empowered the EPA to regulate any new substances for the last 40 years, the organization said, 38 states began regulating dangerous chemicals, including bisphenol A, formaldehyde, lead, mercury and toxic flame retardants. Now, “Congress is ignoring environmental, public health, worker safety, and environmental justice leaders who have championed chemical policy reform for decades. Instead, they chose to listen to the chemical lobbyists from Dow, DuPont, Exxon and their trade associations, like the American Chemistry Council (ACC).”

The new legislation, which will go to President Barack Obama to sign after it passes the US Senate, would roll back most states' authority to take more protective action, Greenpeace said, adding that it would enable the chemical industry to choose up to half of the “meager 40 chemicals” that EPA may prioritize over the next three and a half years. What’s more, it would also be easier for companies to import products containing dangerous chemicals.

The organization has urged Obama to “veto this hijacking of public health.”

If Congress had prioritized the public's health instead of the interests and campaign contributions of the chemical lobby, it could have enacted legislation as strong or stronger than the EU’s REACH, Greenpeace remarked.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.